Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Influence of humic acid and dihydroxy benzoic acid on the agglomeration, adsorption, sedimentation and dissolution of copper, manganese, aluminum and silica nanoparticles - A tentative exposure scenario.

Pradhan S, Hedberg J, Rosenqvist J, Jonsson CM, Wold S, Blomberg E, Odnevall Wallinder I.

PLoS One. 2018 Feb 8;13(2):e0192553. doi: 10.1371/journal.pone.0192553. eCollection 2018.

2.

Nanoparticles of WC-Co, WC, Co and Cu of relevance for traffic wear particles - Particle stability and reactivity in synthetic surface water and influence of humic matter.

Hedberg YS, Hedberg JF, Isaksson S, Mei N, Blomberg E, Wold S, Odnevall Wallinder I.

Environ Pollut. 2017 May;224:275-288. doi: 10.1016/j.envpol.2017.02.006. Epub 2017 Feb 11.

3.

Effect of sonication on particle dispersion, administered dose and metal release of non-functionalized, non-inert metal nanoparticles.

Pradhan S, Hedberg J, Blomberg E, Wold S, Odnevall Wallinder I.

J Nanopart Res. 2016;18(9):285. Epub 2016 Sep 22.

4.

Sequential studies of silver released from silver nanoparticles in aqueous media simulating sweat, laundry detergent solutions and surface water.

Hedberg J, Skoglund S, Karlsson ME, Wold S, Odnevall Wallinder I, Hedberg Y.

Environ Sci Technol. 2014 Jul 1;48(13):7314-22. doi: 10.1021/es500234y. Epub 2014 Jun 19.

5.

Effect of laundry surfactants on surface charge and colloidal stability of silver nanoparticles.

Skoglund S, Lowe TA, Hedberg J, Blomberg E, Wallinder IO, Wold S, Lundin M.

Langmuir. 2013 Jul 16;29(28):8882-91. doi: 10.1021/la4012873. Epub 2013 Jul 2.

6.

Intracranial sarcoid granuloma as an extension of severe sinonasal sarcoidosis.

Wold SM, Sinacori JT.

Ear Nose Throat J. 2012 Apr;91(4):E27-9.

PMID:
22522363
7.

Interactions between surfactants and silver nanoparticles of varying charge.

Hedberg J, Lundin M, Lowe T, Blomberg E, Wold S, Wallinder IO.

J Colloid Interface Sci. 2012 Mar 1;369(1):193-201. doi: 10.1016/j.jcis.2011.12.004. Epub 2011 Dec 11.

PMID:
22204969
8.

Porosity investigation of compacted bentonite using XRD profile modeling.

Holmboe M, Wold S, Jonsson M.

J Contam Hydrol. 2012 Feb 1;128(1-4):19-32. doi: 10.1016/j.jconhyd.2011.10.005. Epub 2011 Oct 20.

PMID:
22192342
9.

Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses.

Wold SM, Derkay CS, Darrow DH, Proud V.

Int J Pediatr Otorhinolaryngol. 2010 Jan;74(1):27-31. doi: 10.1016/j.ijporl.2009.09.042. Epub 2009 Nov 20.

PMID:
19931921
10.

Determining pseudo-equilibrium of montmorillonite colloids in generation and sedimentation experiments as a function of ionic strength, cationic form, and elevation.

García-García S, Degueldre C, Wold S, Frick S.

J Colloid Interface Sci. 2009 Jul 1;335(1):54-61. doi: 10.1016/j.jcis.2009.02.048. Epub 2009 Apr 5.

PMID:
19423125
11.

Going the extra mile: beyond health teaching to political involvement.

Wold SJ, Brown CM, Chastain CE, Griffis MD, Wingate J.

Nurs Forum. 2008 Oct-Dec;43(4):171-6. doi: 10.1111/j.1744-6198.2008.00111.x. Review.

PMID:
19076461
12.

Uranium colloid analysis by single particle inductively coupled plasma-mass spectrometry.

Degueldre C, Favarger PY, Rossé R, Wold S.

Talanta. 2006 Jan 15;68(3):623-8. doi: 10.1016/j.talanta.2005.05.006. Epub 2005 Jun 23.

PMID:
18970366
13.

Kinetic determination of critical coagulation concentrations for sodium- and calcium-montmorillonite colloids in NaCl and CaCl2 aqueous solutions.

García-García S, Wold S, Jonsson M.

J Colloid Interface Sci. 2007 Nov 15;315(2):512-9. Epub 2007 Jul 10.

PMID:
17764680
14.

Temperature effect on the stability of bentonite colloids in water.

García-García S, Jonsson M, Wold S.

J Colloid Interface Sci. 2006 Jun 15;298(2):694-705. Epub 2006 Feb 3.

PMID:
16458320
15.

Summary recommendations for standardization and reporting of metabolic analyses.

Lindon JC, Nicholson JK, Holmes E, Keun HC, Craig A, Pearce JT, Bruce SJ, Hardy N, Sansone SA, Antti H, Jonsson P, Daykin C, Navarange M, Beger RD, Verheij ER, Amberg A, Baunsgaard D, Cantor GH, Lehman-McKeeman L, Earll M, Wold S, Johansson E, Haselden JN, Kramer K, Thomas C, Lindberg J, Schuppe-Koistinen I, Wilson ID, Reily MD, Robertson DG, Senn H, Krotzky A, Kochhar S, Powell J, van der Ouderaa F, Plumb R, Schaefer H, Spraul M; Standard Metabolic Reporting Structures working group.

Nat Biotechnol. 2005 Jul;23(7):833-8. No abstract available.

PMID:
16003371
16.

Three-block bi-focal PLS (3BIF-PLS) and its application in QSAR.

Eriksson L, Damborsky J, Earll M, Johansson E, Trygg J, Wold S.

SAR QSAR Environ Res. 2004 Oct-Dec;15(5-6):481-99.

PMID:
15669704
17.

Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm).

Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S.

Anal Bioanal Chem. 2004 Oct;380(3):419-29. Epub 2004 Sep 22.

PMID:
15448969
20.

Megavariate analysis of hierarchical QSAR data.

Eriksson L, Johansson E, Lindgren F, Sjöström M, Wold S.

J Comput Aided Mol Des. 2002 Oct;16(10):711-26.

PMID:
12650589
21.

School nursing: a framework for practice. 1978.

Wold SJ, Dagg NV.

J Sch Health. 2001 Oct;71(8):401-4. No abstract available.

PMID:
11794290
22.

Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors.

Linusson A, Gottfries J, Olsson T, Ornskov E, Folestad S, Nordén B, Wold S.

J Med Chem. 2001 Oct 11;44(21):3424-39.

PMID:
11585448
23.
24.

Statistical molecular design of building blocks for combinatorial chemistry.

Linusson A, Gottfries J, Lindgren F, Wold S.

J Med Chem. 2000 Apr 6;43(7):1320-8.

PMID:
10753469
25.

Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols).

Domagala JM, Alessi D, Cummings M, Gracheck S, Huang L, Huband M, Johnson G, Olson E, Shapiro M, Singh R, Song Y, Van Bogelen R, Vo D, Wold S.

Adv Exp Med Biol. 1998;456:269-86. Review. No abstract available.

PMID:
10549373
26.

Statistical molecular design of peptoid libraries.

Linusson A, Wold S, Nordén B.

Mol Divers. 1998-1999;4(2):103-14.

PMID:
10425633
27.

Effects of purified SeqA protein on oriC-dependent DNA replication in vitro.

Wold S, Boye E, Slater S, Kleckner N, Skarstad K.

EMBO J. 1998 Jul 15;17(14):4158-65.

28.

New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids.

Sandberg M, Eriksson L, Jonsson J, Sjöström M, Wold S.

J Med Chem. 1998 Jul 2;41(14):2481-91.

PMID:
9651153
29.

Alignment of flexible molecules at their receptor site using 3D descriptors and Hi-PCA.

Berglund A, De Rosa MC, Wold S.

J Comput Aided Mol Des. 1997 Nov;11(6):601-12.

PMID:
9491352
30.

Septic shock in pregnancy associated with legionella pneumonia: case report.

Tewari K, Wold SM, Asrat T.

Am J Obstet Gynecol. 1997 Mar;176(3):706-7.

PMID:
9077632
31.

The Escherichia coli Fis protein prevents initiation of DNA replication from oriC in vitro.

Wold S, Crooke E, Skarstad K.

Nucleic Acids Res. 1996 Sep 15;24(18):3527-32.

32.
33.

The speed of the Escherichia coli fork in vivo depends on the DnaB:DnaC ratio.

Skarstad K, Wold S.

Mol Microbiol. 1995 Sep;17(5):825-31.

PMID:
8596432
34.

Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris.

Pinton J, Fridén H, Kettaneh-Wold N, Wold S, Dreno B, Richard A, Bieber T.

Br J Dermatol. 1995 Aug;133(2):344-7. No abstract available.

PMID:
7547424
35.

The initiation mass for DNA replication in Escherichia coli K-12 is dependent on growth rate.

Wold S, Skarstad K, Steen HB, Stokke T, Boye E.

EMBO J. 1994 May 1;13(9):2097-102.

36.

In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models.

Cohen MA, Wold SA, Meservey MA, Gage JW, Heifetz CL, Mailloux GB, Roland GE, Yoder SL.

Diagn Microbiol Infect Dis. 1994 Jan;18(1):41-7.

PMID:
8026156
37.

Quantitative sequence-activity models (QSAM)--tools for sequence design.

Jonsson J, Norberg T, Carlsson L, Gustafsson C, Wold S.

Nucleic Acids Res. 1993 Feb 11;21(3):733-9.

38.

Chemical purity and mutagenicity: case study of a drug in development.

Kropko ML, Jaen JC, Theiss JC, Wold S, Caprathe BW, Wise LD.

Mutat Res. 1992 Apr;281(4):233-8. Erratum in: Mutat Res 1992 Aug;282(4):287.

PMID:
1373215
39.

A strategy for ranking environmentally occurring chemicals. Part VI. QSARs for the mutagenic effects of halogenated aliphatics.

Eriksson L, Hellberg S, Johansson E, Jonsson J, Sjöström M, Wold S, Berglind R, Karlsson B.

Acta Chem Scand. 1991 Oct;45(9):935-44.

PMID:
1793683
40.

Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships.

Hellberg S, Eriksson L, Jonsson J, Lindgren F, Sjöström M, Skagerberg B, Wold S, Andrews P.

Int J Pept Protein Res. 1991 May;37(5):414-24.

PMID:
1917297
41.

A multivariate representation and analysis of DNA sequence data.

Jonsson J, Eriksson L, Hellberg S, Lindgren F, Sjöström M, Wold S.

Acta Chem Scand. 1991 Feb;45(2):186-92.

PMID:
2021500
42.

A chemometric study of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in Great Lakes fish.

Dunn WJ, Stalling DL, Schwartz TR, De Vault D, Wold S, Bergqvist PA, Wiberg K, Rappe C.

IARC Sci Publ. 1991;(108):175-80. Review. No abstract available.

PMID:
1817096
43.

Interpreting complicated chromatographic patterns.

Jellum E, Harboe M, Bjune G, Wold S.

J Pharm Biomed Anal. 1991;9(8):663-9.

PMID:
1790187
44.

Chemometrics, why, what and where to next?

Wold S.

J Pharm Biomed Anal. 1991;9(8):589-96. Review.

PMID:
1790178
45.

Peptide QSAR on substance P analogues, enkephalins and bradykinins containing L- and D-amino acids.

Eriksson L, Jonsson J, Hellberg S, Lindgren F, Skagerberg B, Sjöström M, Wold S.

Acta Chem Scand. 1990 Jan;44(1):50-5.

PMID:
1698414
46.

A multivariate approach to saccharide quantitative structure-activity relationships exemplified by two series of 9-hydroxyellipticine glycosides.

Jonsson J, Eriksson L, Hellberg S, Sjöström M, Wold S.

Acta Chem Scand. 1989 Mar;43(3):286-9.

PMID:
2486132
47.

Peptide QSARS: PLS modelling and design in principal properties.

Sjöström M, Eriksson L, Hellberg S, Jonsson J, Skagerberg B, Wold S.

Prog Clin Biol Res. 1989;291:313-7. No abstract available.

PMID:
2726864
48.

Multivariate parametrization of coded and non-coded amino acids by thin layer chromatography.

Eriksson L, Jonsson J, Sjöström M, Wold S.

Prog Clin Biol Res. 1989;291:131-4. No abstract available.

PMID:
2726834
49.

Principal properties of aromatic substituents.

Skagerberg B, Clementi S, Sjöström M, Tosato ML, Wold S.

Prog Clin Biol Res. 1989;291:127-30. No abstract available.

PMID:
2726833
50.

Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.

Heifetz CL, Bien PA, Cohen MA, Dombrowski ME, Griffin TJ, Malta TE, Sesnie JC, Shapiro MA, Wold SA.

J Antimicrob Chemother. 1988 Feb;21 Suppl B:29-42.

PMID:
3129392

Supplemental Content

Support Center